Cargando…
OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523140/ http://dx.doi.org/10.1016/j.jtho.2021.08.036 |
_version_ | 1784585235191562240 |
---|---|
author | Hijmering-Kappelle, L. Hiltermann, T.j.n. Bensch, F. |
author_facet | Hijmering-Kappelle, L. Hiltermann, T.j.n. Bensch, F. |
author_sort | Hijmering-Kappelle, L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8523140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85231402021-10-20 OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience Hijmering-Kappelle, L. Hiltermann, T.j.n. Bensch, F. J Thorac Oncol Oa01 the Impact of Covid-19 on Patients with Lung Cancer Wednesday, September 08, 2021 - 08:15-09:15 Published by Elsevier Inc. 2021-10 2021-10-18 /pmc/articles/PMC8523140/ http://dx.doi.org/10.1016/j.jtho.2021.08.036 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Oa01 the Impact of Covid-19 on Patients with Lung Cancer Wednesday, September 08, 2021 - 08:15-09:15 Hijmering-Kappelle, L. Hiltermann, T.j.n. Bensch, F. OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience |
title | OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience |
title_full | OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience |
title_fullStr | OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience |
title_full_unstemmed | OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience |
title_short | OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience |
title_sort | oa01.03 immune checkpoint inhibitor dose adaptation during the covid-19 pandemic in non-small cell lung cancer– a single-center experience |
topic | Oa01 the Impact of Covid-19 on Patients with Lung Cancer Wednesday, September 08, 2021 - 08:15-09:15 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523140/ http://dx.doi.org/10.1016/j.jtho.2021.08.036 |
work_keys_str_mv | AT hijmeringkappellel oa0103immunecheckpointinhibitordoseadaptationduringthecovid19pandemicinnonsmallcelllungcancerasinglecenterexperience AT hiltermanntjn oa0103immunecheckpointinhibitordoseadaptationduringthecovid19pandemicinnonsmallcelllungcancerasinglecenterexperience AT benschf oa0103immunecheckpointinhibitordoseadaptationduringthecovid19pandemicinnonsmallcelllungcancerasinglecenterexperience |